Abstract
Since its inception in 1969, the NWTSG has performed successful studies that are now the model for the management of pediatric malignancies. Future studies may use genetic markers to stratify high-risk patients beyond the traditional staging system. Therapy will continue to be evaluated to determine the minimal therapy necessary to achieve the best outcome for children with Wilms' tumor.
Original language | English (US) |
---|---|
Pages (from-to) | 435-442 |
Number of pages | 8 |
Journal | Urologic Clinics of North America |
Volume | 27 |
Issue number | 3 |
DOIs | |
State | Published - 2000 |
ASJC Scopus subject areas
- Urology